Lead Innovation Corporation
LEIC
$0.254
-$0.046-15.33%
Weiss Ratings | LEIC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Unrated | |||
Risk Index | Unrated | |||
Risk Grade | U | |||
Reward Grade | U | |||
Rating Factors | LEIC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Unrated | |||
Growth Index | Unrated | |||
Efficiency Index | Unrated | |||
Solvency Index | Unrated | |||
Total Return Index | Unrated | |||
Volatility Index | Unrated | |||
Beta / Standard Deviation | LEIC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -0.09 | |||
Price History | LEIC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 0.40% | |||
60-Day Total Return | -29.64% | |||
90-Day Total Return | -45.36% | |||
Year to Date Total Return | 0.40% | |||
1-Year Total Return | 41.03% | |||
2-Year Total Return | -74.46% | |||
3-Year Total Return | -66.13% | |||
5-Year Total Return | -66.13% | |||
52-Week High % Change | -56.95% | |||
52-Week Low % Change | 284.85% | |||
Price | LEIC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.59 | |||
52-Week Low Price | $0.07 | |||
52-Week Low Price (Date) | Jun 20, 2024 | |||
52-Week High Price (Date) | Sep 17, 2024 | |||
Valuation | LEIC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 133.72M | |||
Enterprise Value | -- | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -- | |||
Earnings Per Share Growth | -- | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | -- | |||
Price/Book (Q) | -- | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | $0.25 | |||
Enterprise Value/EBITDA (TTM) | -- | |||
Enterprise Value/EBIT | -- | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | LEIC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | -- | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | LEIC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 573-415-9201 | |||
Address | 1301 Southwest Bolvered Jefferson City, MO 65109 | |||
Website | -- | |||
Country | United States | |||
Year Founded | -- | |||
Profitability | LEIC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | LEIC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | -- | |||
Income Statement | LEIC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | -- | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | -- | |||
Net Income Avl. to Common (TTM) | -- | |||
Total Revenue Growth (Q YOY) | -50.68% | |||
Earnings Growth (Q YOY) | -166.14% | |||
EPS Diluted (TTM) | -- | |||
EPS Diluted Growth (Q YOY) | -- | |||
Balance Sheet | LEIC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 700.00 | |||
Cash Per Share (Q) | $0.04 | |||
Total Current Assets (Q) | 172.20K | |||
Total Preferred Equity (Q) | 1.57 | |||
Total Equity (Q) | 179.80K | |||
Current Ratio (Q) | 0.291 | |||
Book Value Per Share (Q) | -- | |||
Total Assets (Q) | -- | |||
Total Current Liabilities (Q) | 592.40K | |||
Total Debt (Q) | -- | |||
Total Liabilities (Q) | -- | |||
Total Common Equity (Q) | -1.39M | |||
Cash Flow | LEIC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -- | |||